A2 Biotherapeutics
Agoura Hills
About A2 Biotherapeutics
A2 Biotherapeutics focuses on innovative T cell therapies that precisely distinguish between solid tumors and normal cells. The proprietary Tmod™ platform integrates multiple signals to enhance treatment effectiveness while minimizing damage to healthy tissue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $270.8M
- Funding stage: Late Stage Venture
- Last round: Grant (May 2025)
- Website: a2bio.com
- Phone: 805-491-1988
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/a2-biotherapeutics-39481 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.